{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-101103","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2025-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.612287+00:00","generated_at":"2026-05-17T21:52:05.240055+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fulgent Q2 core revenue $81.7M (+16% YoY); raises FY2025 guidance to $320M","bullets":["Core revenue $81.7M, up 16% YoY; total revenue $81.8M.","GAAP net loss $19.0M ($0.62 per share) includes one-time charge; non-GAAP net income $2.1M ($0.07 per share).","Adjusted EBITDA loss of $3.0M.","Raising full-year 2025 core revenue guidance to $320M.","Cash and investments $777.5M at June 30; repurchased ~130k shares for $2.2M in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-101103","json":"https://secwatch.observer/filing/0000950170-25-101103.json","markdown":"https://secwatch.observer/filing/0000950170-25-101103.md","text":"https://secwatch.observer/filing/0000950170-25-101103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/0000950170-25-101103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017025101103/flgt-20250801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:52:05.240055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}